Atractylenolide I enhances responsiveness to immune checkpoint blockade therapy by activating tumor antigen presentation H Xu, K Van der Jeught, Z Zhou, L Zhang, T Yu, Y Sun, Y Li, C Wan, ... The Journal of clinical investigation 131 (10), 2021 | 103 | 2021 |
Inhibition of breast cancer metastases by a novel inhibitor of TGFβ receptor 1 Y Fang, Y Chen, L Yu, C Zheng, Y Qi, Z Li, Z Yang, Y Zhang, T Shi, J Luo, ... Journal of the National Cancer Institute 105 (1), 47-58, 2013 | 102 | 2013 |
Bcl-xL promotes metastasis independent of its anti-apoptotic activity S Choi, Z Chen, LH Tang, Y Fang, SJ Shin, NC Panarelli, YT Chen, Y Li, ... Nature communications 7 (1), 10384, 2016 | 90 | 2016 |
MAL2 drives immune evasion in breast cancer by suppressing tumor antigen presentation Y Fang, L Wang, C Wan, Y Sun, K Van der Jeught, Z Zhou, T Dong, ... The Journal of clinical investigation 131 (1), 2021 | 73 | 2021 |
Synthesis and biological evaluation of novel tetrahydro-β-carboline derivatives as antitumor growth and metastasis agents through inhibiting the transforming growth factor-β … C Zheng, Y Fang, W Tong, G Li, H Wu, W Zhou, Q Lin, F Yang, Z Yang, ... Journal of medicinal chemistry 57 (3), 600-612, 2014 | 68 | 2014 |
LGR4 modulates breast cancer initiation, metastasis, and cancer stem cells Z Yue, Z Yuan, L Zeng, Y Wang, L Lai, J Li, P Sun, X Xue, J Qi, Z Yang, ... The FASEB Journal 32 (5), 2422, 2018 | 66 | 2018 |
Targeting 17q23 amplicon to overcome the resistance to anti-HER2 therapy in HER2+ breast cancer Y Liu, J Xu, HH Choi, C Han, Y Fang, Y Li, K Van der Jeught, H Xu, ... Nature communications 9 (1), 4718, 2018 | 58 | 2018 |
An organoid-based screen for epigenetic inhibitors that stimulate antigen presentation and potentiate T-cell-mediated cytotoxicity Z Zhou, K Van der Jeught, Y Fang, T Yu, Y Li, Z Ao, S Liu, L Zhang, ... Nature biomedical engineering 5 (11), 1320-1335, 2021 | 56 | 2021 |
Comparative analysis of human protein-coding and noncoding RNAs between brain and 10 mixed cell lines by RNA-Seq G Chen, K Yin, L Shi, Y Fang, Y Qi, P Li, J Luo, B He, M Liu, T Shi PloS one 6 (11), e28318, 2011 | 40 | 2011 |
Heterozygous deletion of chromosome 17p renders prostate cancer vulnerable to inhibition of RNA polymerase II Y Li, Y Liu, H Xu, G Jiang, K Van der Jeught, Y Fang, Z Zhou, L Zhang, ... Nature communications 9 (1), 4394, 2018 | 38 | 2018 |
Somatic mutation of the cohesin complex subunit confers therapeutic vulnerabilities in cancer Y Liu, H Xu, K Van der Jeught, Y Li, S Liu, L Zhang, Y Fang, X Zhang, ... The Journal of clinical investigation 128 (7), 2951-2965, 2018 | 36 | 2018 |
ST2 as checkpoint target for colorectal cancer immunotherapy K Van der Jeught, Y Sun, Y Fang, Z Zhou, H Jiang, T Yu, J Yang, ... JCI insight 5 (9), 2020 | 32 | 2020 |
Caffeic acid 3, 4-dihydroxy-phenethyl ester induces cancer cell senescence by suppressing twist expression A Dong, Y Fang, L Zhang, J Xie, X Wu, L Zhang, X Lian, Y Chen, J Luo, ... Journal of Pharmacology and Experimental Therapeutics 339 (1), 238-247, 2011 | 27 | 2011 |
MicroRNAs in DNA damage response, carcinogenesis, and chemoresistance Y Fang, L Zhang, Z Li, Y Li, C Huang, X Lu International Review of Cell and Molecular Biology 333, 1-49, 2017 | 22 | 2017 |
Inhibition of non-small cell lung cancer (NSCLC) growth by a novel small molecular inhibitor of EGFR J Li, H Deng, M Hu, Y Fang, A Vaughn, X Cai, L Xu, W Wan, Z Li, S Chen, ... Oncotarget 6 (9), 6749, 2015 | 14 | 2015 |
Metabolic interventions: a new insight into the cancer immunotherapy T Yu, T Dong, H Eyvani, Y Fang, X Wang, X Zhang, X Lu Archives of biochemistry and biophysics 697, 108659, 2021 | 7 | 2021 |
浅谈癌症及其治疗方法 房元章 生物学教学 30 (1), 61, 2005 | 2 | 2005 |
Author Correction: An organoid-based screen for epigenetic inhibitors that stimulate antigen presentation and potentiate T-cell-mediated cytotoxicity Z Zhou, K Van der Jeught, Y Fang, T Yu, Y Li, Z Ao, S Liu, L Zhang, ... Nature Biomedical Engineering, 1-1, 2023 | | 2023 |
低频脉冲电场对 PC12 细胞酪氨酸氢化酶和多巴胺合成的影响 房元章, 余晓君, 张红锋, 陈树德 细胞生物学杂志 29, 394-398, 2007 | | 2007 |